Anastomosis Devices Market Size, Share and Industry Analysis Report, Regional Outlook, Growth Potential, Competitive Market Share & Forecast, 2025 – 2034

Anastomosis Devices Market Size

The global anastomosis devices market generated substantial revenues in 2024 and is projected to grow at a substantial CAGR during 2025-2034, driven by a rise in surgical procedures, advancements in medical technology, and rising demand for minimally invasive surgical procedures. Anastomosis devices, which surgeons use to join blood vessels, organs, or tissue during a surgical procedure, are widely recognized for their contributions and popularity in promoting faster recovery time for patients.

Anastomosis devices will be increasingly relevant in the above-patient population and even more so in cardiac surgery, gastrointestinal surgeries, and oncology surgeries where suturing needs to be precise and safe. The global anastomosis devices market is expected to grow commensurate with the growing number of surgeries and the increase in anastomosis devices. As the number of chronic diseases is increasing and the population continues to age, it is likely that the number of surgical procedures will be on the rise, propelling the use of anastomosis devices.
 

As per CDC.gov, nearly 60% of Americans suffer from at least one chronic disease, while 40% are affected by two or more chronic conditions. A significant restraining factor within the anastomosis devices market is the excessive price of advanced surgical devices. These devices, particularly devices for minimally invasive surgeries or devices with complex technologies, usually involve significant R&D costs that require a high selling price relative to traditional surgical devices.
 

Anastomosis Devices Market Trends

The anastomosis devices industry is experiencing many trends that will drive its growth in the future. The most significant is the increasing use of minimally invasive surgical procedures that decrease patient recovery time, length of hospital stay, and healthcare costs. As the number of anastomosis devices that can be used in minimally invasive surgical procedures are well documented and surgical techniques continue to evolve, the market for anastomosis devices will only grow.
 

Advances in surgical procedures involving a laparoscope or robotic-assisted surgical facility have made complex surgical procedures easier and more efficient and have become more prized as they perform better than ever before when it comes to precision, reliability, and handling. Another trend is utilizing biodegradable materials in manufacturing anastomosis devices. The development of biodegradable sutures and anastomosis devices as well as sutures will be absorbed over time, thus limiting the need for a procedure to remove anastomosis devices.
 

Along with improving patient outcomes, using biodegradable anastomosis devices and sutures limits the risk of complications and infections. Furthermore, advances in technology have enabled the development of anastomosis devices capable of assisting in the implementation of robotic-assisted surgical platforms and developing automated anastomosis devices that will enhance surgical precision. As technology advances improvements in robot-assisted surgery will only improve surgical efficiency and accuracy.
 

Anastomosis Devices Market Analysis

The reusable anastomosis devices segment held the largest share in 2024 due to their affordability and sustainability. In many cases, hospitals and surgical centers prefer reusable devices because they can be sterilized and reused numerous times, lowering the per-use cost. These devices can be constructed using a variety of high-quality materials that withstand repeated sterilization and usage, but many hospitals still strive to save operational costs. The growing integration of reusable loops and various sterilization systems has proven highly beneficial. These systems improve both performance and affordability.
 

Additionally, modern sterilization technologies ensure that multi-use or reusable devices can be thoroughly cleaned. This makes them safe for repeated use. Lower operational and single-use items, like disposable scopes, are being replaced by non-disposal and reusable devices, as hospitals and surgical centers are looking at the value of quality and the value of the eco-friendly component. In the current medical advance for sustainable disposable devices for patients, there's a slow reality to replace those disposable-based tools.
 

The anastomosis devices market from cardiovascular segment generated notable revenues in 2024. Many cardiovascular procedures and surgeries involve anastomosis that is precise for coronary artery bypass grafting (CABG), valve replacement, and other procedures that reestablish or connect blood vessels. Cardiovascular diseases (CVD) are one of the leading causes of death all over the world. Furthermore, this has shifted the demand for surgical interventions such as anastomosis devices. Many anastomosis devices are required for surgical procedures and represent the highest possible level of quality and skill during cardiovascular surgeries—given that re-establishing any blood vessel connection is paramount for both patient survival and recovery in any surgical operation.
 

Given the technological advancements in cardiovascular anastomosis devices such as robotic-assisted anastomosis devices, and the creation of even more efficient suturing devices, this will lead to high growth for this segment as well. As healthcare organizations strive for higher-quality outcomes and reduced recovery times, this segment will continue to grow as chronic diseases will further require advanced, reliable, and easy-to-use anastomosis devices. The increase in the number of people suffering from hypertension, diabetes, and other advanced stages of chronic disease is also fuelling increased CVD patterns globally.
 

North America anastomosis devices market generated notable revenues in 2024 driven by the prevalence of chronic diseases, strong healthcare infrastructure, and an enviable level of adoption of new and innovative medical technology. The United States is a significant part of this vast market and was developed as one of the strongest and best medical systems in the world in terms of medical devices and their use. The number of surgeries continues to grow annually, particularly in cardiovascular and gastrointestinal cases.
 

This strong demand for hospitals to carry out surgical procedures allowed considerable growth in demand for various anastomosis devices. Additionally, many key medical device manufacturers in this region continue to innovate and create new products. Furthermore, the demand for minimally invasive surgeries and robotic surgery platforms is expected to further expand the market for anastomosis devices. Countless specialized devices to facilitate precise and efficient surgical procedures are expected to keep growing. Finally, the procedure cost is reimbursed and has expanded continuing to be a supportive factor for the anastomosis device market.  
 

Anastomosis Devices Market Share

Key players involved in the anastomosis devices industry include:

• Vitalitec
• Ethicon
• Medtronic
• Aesdex
• Getinge LLC
• Novare Surgical Systems Inc.
• Synovis Micro Companies Alliance
• LivaNova
• B. Braun Melsungen
• Medical Devices Business Services Inc.
   

Leading companies in the anastomosis devices market are adopting several strategies to strengthen their market position. One key strategy is continuous investment in research and development (R&D) to innovate and improve the functionality of anastomosis devices. Companies are focusing on creating devices that are easier to use, more precise, and more adaptable to various surgical techniques, including minimally invasive and robotic surgeries. Strategic partnerships and collaborations with hospitals, research institutions, and surgical device manufacturers also play a key role in expanding product offerings and enhancing market reach.
 

Another critical strategy is the expansion of manufacturing capabilities and distribution networks. By increasing production capacities and establishing strong distribution channels, companies are ensuring that their products reach a broader customer base, particularly in emerging markets where the demand for advanced medical devices is growing. Additionally, companies are increasingly focused on enhancing product offerings with biodegradable and biocompatible materials, catering to the growing demand for safer and more effective solutions in surgery.
 

Anastomosis Devices Industry News

• In September 2024, GT Metabolic™ Solutions, Inc., a company focused on transforming bariatric, metabolic, and digestive surgery, announced that its first-generation MagDI™ System for side-to-side duodeno-ileal anastomosis received De Novo marketing authorization from the U.S. Food and Drug Administration (FDA).
   
• In May 2024, Exero Medical initiated its new, international, pivotal, multi-center study for the xBar system. The xBar, an FDA breakthrough-designated medical device, used innovative post-surgical tissue monitoring technology. It delivered timely, accurate data on postoperative healing, helping personalize patient care and quickly detect potential life-threatening complications after gastrointestinal surgery.